It seems that not all Medicare was created the same. Since Medicare is a national government-issued insurance program created in 1965, one would think that every state would have to follow the same rules and coverage policies. But that is not so.
It seems that not all Medicare was created the same. Since Medicare is a national government-issued insurance program created in 1965, one would think that every state would have to follow the same rules and coverage policies. But that is not so. Every region contracts out with a private company (Medicare carrier) to operate as the intermediary between the government and medical providers.
These private companies have the authority to create local coverage determinations that spell out coverage criteria and diagnoses for certain CPT codes. If you deal with multiple practices in different states, you are most likely going to have to deal with different carriers, which can be a headache.
For example, if you have a lot of patients with memory loss, you may want to have your practice in snowy Indiana where a diagnosis of 780.93 is on the local coverage determination for an MRI of the brain. However, stay away from warm Texas because memory loss is not the local coverage determination for MRI of the brain. Why is it that a certain diagnosis justifies an exam in one state but not another?
Recently, New Jersey came out with a bulletin stating the physicians must justify the use of ultrasound on a knee injection by meeting certain conditions, such as the patient being morbidly obese. So far, I can find no other carrier with such a specification.
Coding across states can be challenging. It is important for your coders to be diverse in their knowledge of each carrier’s local coverage policies; it can mean the difference between payment and denial.
Ms. Snyder is corporate director of coding for Zotec Partners.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.